share_log

Sidoti & Co. Downgrades Surmodics to Neutral, Announces $43 Price Target

Benzinga ·  May 30 00:40

Sidoti & Co. analyst James Sidoti downgrades Surmodics (NASDAQ:SRDX) from Buy to Neutral and announces $43 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment